Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano
1.
Chinese Traditional and Herbal Drugs ; 54(8):2523-2535, 2023.
Artigo em Chinês | EMBASE | ID: covidwho-20235800

RESUMO

Objective To explore the core targets and important pathways of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induced atherosclerosis (AS) progression from the perspective of immune inflammation, so as to predict the potential prevention and treatment of traditional Chinese medicine (TCM). Methods Microarray data were obtained from the Gene Expression Omnibus (GEO) database for coronavirus disease 2019 (COVID-19) patients and AS patients, and the "limmar" and "Venn" packages were used to screen out the common differentially expressed genes (DEGs) genes in both diseases. The gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) analyses were performed on the common DEGs to annotate their functions and important pathways. The two gene sets were scored for immune cells and immune function to assess the level of immune cell infiltration. The protein-protein interaction (PPI) network was constructed by STRING database, and the CytoHubba plug-in of Cytoscape was used to identify the hub genes. Two external validation datasets were introduced to validate the hub genes and obtain the core genes. Immuno-infiltration analysis and gene set enrichment analysis (GSEA) were performed on the core genes respectively. Finally the potential TCM regulating the core genes were predicted by Coremine Medical database. Results A total of 7898 genes related to COVID-19, 471 genes related to AS progression;And 51 common DEGs, including 32 highly expressed genes and 19 low expressed genes were obtained. GO and KEGG analysis showed that common DEGs, which were mainly localized in cypermethrin-encapsulated vesicles, platelet alpha particles, phagocytic vesicle membranes and vesicles, were involved in many biological processes such as myeloid differentiation factor 88 (MyD88)-dependent Toll-like receptor signaling pathway transduction, interleukin-8 (IL-8) production and positive regulation, IL-6 production and positive regulation to play a role in regulating nicotinamide adenine dinucleotide phosphate oxidase activity, Toll-like receptor binding and lipopeptide and glycosaminoglycan binding through many biological pathways, including Toll-like receptor signaling pathways, neutrophil extracellular trap formation, complement and coagulation cascade reactions. The results of immune infiltration analysis demonstrated the state of immune microenvironment of COVID-19 and AS. A total of 5 hub genes were obtained after screening, among which Toll-like receptor 2 (TLR2), cluster of differentiation 163 (CD163) and complement C1q subcomponent subunit B (C1QB) genes passed external validation as core genes. The core genes showed strong correlation with immune process and inflammatory response in both immune infiltration analysis and GSEA enrichment analysis. A total of 35 TCMs, including Chuanxiong (Chuanxiong Rhizoma), Taoren (Persicae Semen), Danggui (Angelicae Sinensis Radix), Huangqin (Scutellariae Radix), Pugongying (Taraxaci Herba), Taizishen (Pseudostellariae Radix), Huangjing (Polygonati Rhizoma), could be used as potential therapeutic agents. Conclusion TLR2, CD163 and C1QB were the core molecules of SARS-CoV-2-mediated immune inflammatory response promoting AS progression, and targeting predicted herbs were potential drugs to slow down AS progression in COVID-19 patients.Copyright © 2023 Editorial Office of Chinese Traditional and Herbal Drugs. All rights reserved.

2.
Journal of Chinese medicinal materials ; 44(4):1031-1038, 2021.
Artigo em Chinês | EMBASE | ID: covidwho-2145401

RESUMO

Objective: To analyze the action mechanism of anti-Corona Virus Disease 2019(COVID-19)by Chinese herbal compound and propose a combination of Chinese medicine through network pharmacology and molecular docking. Method(s): Based on the Chinese medicine and Chinese medicine prescription for prevention and treatment of COVID-19, ADME properties(OB>=30%;DL>=0.18)was used for virtual screening;Potentially active molecules in protease Mpro and receptor ACE2 were screened by molecular docking(Binding Scores>4);Through the overlap ratio of active components and key targets, the suggestions on optimizing formula combination were provided. Result(s): 127 Chinese medicinal materials and 885 active components were obtained. The active components close to Lopinavie scores included squalene, shikonin, stigmasterol, etc. The traditional chinese medicinal materials with overlap rate of active molecules>=15% included Ephedrae Herba, Lonicerae Japonicae Flos, Scutellariae Radix, etc. The key Chinese herbal medicines with overlapping rate of key targets>=15% included Glycyrrhizae Radix et Rhizoma, Pinelliae Rhizoma, Curcumae Radix, etc. Conclusion(s): The combinations of Chinese herbal are proposed:(1)Ephedrae Herba, Armeniacae Semen Amarum, Glycyrrhizae Radix et Rhizoma, Curcumae Longae Rhizoma;(2)Lonicerae Japonicae Flos, Scutellariae Radix, Arnebiae Radix, Verbenae Herba;(3)Ephedrae Herba, Pinelliae Rhizoma, Curcumae Radix, Pseudostellariae Radix. Copyright © 2021, Central Station of Chinese Medicinal Materials Information, National Medical Products Administration. All right reserved.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA